Phillyrin sensitizes lung cancer cells to ferroptosis through inhibiting FTH1/ SLC7A11 axis

被引:4
|
作者
Tang, Xu [1 ]
Teng, Jiajia [2 ]
Lu, Keyin [3 ]
机构
[1] Yueyang Peoples Hosp, Dept Intens Care Unit, Yueyang, Peoples R China
[2] Hunan Inst Sci & Technol, Dept Chem & Chem Engn, Yueyang, Peoples R China
[3] Yueyang Peoples Hosp, Dept Anesthesiol, West Baling Rd, Yueyang 414020, Hunan, Peoples R China
关键词
phillyrin; non-small cell; lung cancer; ferroptosis; FTH1; INFLAMMATION;
D O I
10.5414/CP204475
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ferroptosis is a newly found form of non-apoptotic regulated cell death that is essential for cancer progression. Phillyrin (PHN), an effective lignan glycoside of Forsythia suspensa, has been explored as a potential anticancer agent in some can-cer types. However, it is unclear whether and how PHN could promote the death of non-small cell lung cancer (NSCLC) cells by inducing ferroptosis. Our study showed for the first time that PHN induced cell death and attenuated cell proliferation in NSCLC cells in vitro and in vivo. Functional assays showed that ferroptosis was the predomi-nant form that contributed to PHN-induced cell death of NSCLC cells. Mechanistically, NSCLC cells exposed to PHN had a decreased ferritin heavy chain 1 (FTH1) and SLC7A11 protein expression. Exogenetic overexpres-sion of FTH1 substantially abrogated the tumor-inhibiting effects of PHN and further upregulated the expression of SLC7A11 in NSCLC cells. In conclusion, our findings sug-gest that the natural product PHN exerted its antitumor activity in NSCLC by promot-ing ferroptosis, and the FTH1/SLC7A11 axis plays an indispensable role in PHN-induced ferroptotic cell death.
引用
收藏
页码:8 / 19
页数:12
相关论文
共 50 条
  • [41] Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
    Ming Lei
    Yun-Long Zhang
    Feng-Ying Huang
    Heng-Yu Chen
    Ming-Hui Chen
    Ri-Hong Wu
    Shu-Zhen Dai
    Gui-Sheng He
    Guang-Hong Tan
    Wu-Ping Zheng
    Scientific Reports, 13
  • [42] Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells
    Lei, Ming
    Zhang, Yun-Long
    Huang, Feng-Ying
    Chen, Heng-Yu
    Chen, Ming-Hui
    Wu, Ri-Hong
    Dai, Shu-Zhen
    He, Gui-Sheng
    Tan, Guang-Hong
    Zheng, Wu-Ping
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [43] Vitamin D Promotes Ferroptosis in Colorectal Cancer Stem Cells via SLC7A11 Downregulation
    Guo S.
    Zhao W.
    Zhang W.
    Li S.
    Teng G.
    Liu L.
    Oxidative Medicine and Cellular Longevity, 2023, 2023
  • [44] INHIBITING xCT/SLC7A11 INDUCES FERROPTOSIS OF MYOFIBROBLASTIC HEPATIC STELLATE CELLS AND PROTECTS AGAINST LIVER FIBROSIS
    Du, Kuo
    Oh, Seh-Hoon
    Wang, Ying
    Abdelmalek, Manal F.
    Diehl, Anna Mae
    HEPATOLOGY, 2019, 70 : 874A - 874A
  • [45] Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down
    Guan, Zhenhua
    Chen, Jing
    Li, Xueliang
    Dong, Na
    BIOSCIENCE REPORTS, 2020, 40
  • [46] Valtrate antagonizes malignant phenotypes of lung cancer cells by reducing SLC7A11
    Xu, Wei
    Yu, Huan
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [47] Valtrate antagonizes malignant phenotypes of lung cancer cells by reducing SLC7A11
    Xu, Wei
    Yu, Huan
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [48] FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM
    Wang, Nan
    Shi, Bin
    Ding, Lu
    Zhang, Xu
    Ma, Xiaolan
    Guo, Songlin
    Qiao, Xia
    Wang, Libin
    Ma, Duan
    Cao, Jia
    REDOX BIOLOGY, 2024, 77
  • [49] Alantolactone facilitates ferroptosis in non-small cell lung cancer through promoting FTH1 ubiquitination and degradation
    Huang, Yijiao
    Xiang, Pei
    Chen, Yuanyuan
    Pan, Qi
    Yuan, Kemiao
    CHEMICAL BIOLOGY & DRUG DESIGN, 2024, 104 (02)
  • [50] SLC7A11, a Potential Therapeutic Target Through Induced Ferroptosis in Colon Adenocarcinoma
    Cheng, Xin
    Wang, Yadong
    Liu, Liangchao
    Lv, Chenggang
    Liu, Can
    Xu, Jingyun
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9